HS135, a novel activin and GDF trap, is highly efficacious in preclinical models of pulmonary hypertension and obesity-associated heart failure with preserved ejection fraction
25 August 2023 (07:30 - 18:30)
Organised by: 
About the speaker
35Pharma Inc., Montreal (Canada)
7 More presentations in this session
Doctor V. Bazioti (Munich, DE)
Associate Professor A. Lymperopoulos (Fort Lauderdale, US)
Ms M. Labonia (Utrecht, NL)
Doctor L. Xu (Shanghai, CN)
Access the full session
The Event
ESC Congress 2023
25 August - 28 August 2023
You may be interested in
Congress Presentation
Congress Presentation
Congress Session
